Switzerland’s divided cabinet looks bound for a clash with the European Union with its likely rebuff of a draft treaty that has exposed deep divisions in Swiss attitudes towards its biggest trading partner.

ROCHE

The drugmaker said that its Tecentriq immunotherapy in combination with chemotherapy was approved by the U.S. Food and Drug Administration as a first-line treatment for a type of lung cancer.

NOVARTIS

The drugmaker said its U.S. unit Sandoz Inc. will launch Adamis Pharmaceuticals Corp’s emergency allergy shots next year in the United States at a price that is about 16 percent below that of similar rival products.

MEYER BURGER

Meyer Burger’s largest shareholder called for the money-losing solar machinery maker to renew its board of directors and to consider raising money to finance its own efforts to manufacture solar cells.